Skip to content
10-Q

Quarterly Report

CHELSEA THERAPEUTICS INTERNATIONAL, LTD.

0001144204-14-029111

← back to feed
Filed
May 9, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 8, 2014 78.94M sh
Capex Q1 2014 · Mar 31, 2014 $0
Capex Q1 2014 · Mar 31, 2014 $742.72K
Capex Q1 2014 · Mar 31, 2013 $0
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$6.73M
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$221.71M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$3.37M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $37.09M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $45.32M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $25.06M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $28.42M
Cash And Equivalents Q1 2014 · Apr 2, 2002 $0
Stockholders Equity Q1 2014 · Mar 31, 2014 $35.89M
Stockholders Equity Q1 2014 · Dec 31, 2013 $43.26M
Total Liabilities Q1 2014 · Mar 31, 2014 $3.97M
Total Liabilities Q1 2014 · Dec 31, 2013 $3.25M
Current Assets Q1 2014 · Mar 31, 2014 $38.33M
Current Assets Q1 2014 · Dec 31, 2013 $46.46M
Total Assets Q1 2014 · Mar 31, 2014 $39.86M
Total Assets Q1 2014 · Dec 31, 2013 $46.5M
Sga Expense Q1 2014 · Mar 31, 2014 $2.47M
Sga Expense Q1 2014 · Mar 31, 2014 $38.35M
Sga Expense Q1 2014 · Mar 31, 2013 $1.61M
Rd Expense Q1 2014 · Mar 31, 2014 $4.22M
Rd Expense Q1 2014 · Mar 31, 2014 $177.1M
Rd Expense Q1 2014 · Mar 31, 2013 $1.96M
Net Income Q1 2014 · Mar 31, 2014 −$8.07M
Net Income Q1 2014 · Mar 31, 2014 −$239.55M
Net Income Q1 2014 · Mar 31, 2013 −$3.92M
Operating Income Q1 2014 · Mar 31, 2014 −$8.08M
Operating Income Q1 2014 · Mar 31, 2014 −$244.32M
Operating Income Q1 2014 · Mar 31, 2013 −$3.92M